收费全文 | 17624篇 |
免费 | 1941篇 |
国内免费 | 709篇 |
耳鼻咽喉 | 45篇 |
儿科学 | 231篇 |
妇产科学 | 118篇 |
基础医学 | 3545篇 |
口腔科学 | 204篇 |
临床医学 | 1523篇 |
内科学 | 2734篇 |
皮肤病学 | 209篇 |
神经病学 | 658篇 |
特种医学 | 403篇 |
外国民族医学 | 3篇 |
外科学 | 975篇 |
综合类 | 2300篇 |
现状与发展 | 6篇 |
预防医学 | 1193篇 |
眼科学 | 166篇 |
药学 | 3133篇 |
7篇 | |
中国医学 | 1168篇 |
肿瘤学 | 1653篇 |
2024年 | 66篇 |
2023年 | 424篇 |
2022年 | 540篇 |
2021年 | 971篇 |
2020年 | 863篇 |
2019年 | 746篇 |
2018年 | 671篇 |
2017年 | 709篇 |
2016年 | 803篇 |
2015年 | 870篇 |
2014年 | 1181篇 |
2013年 | 1416篇 |
2012年 | 1110篇 |
2011年 | 1068篇 |
2010年 | 834篇 |
2009年 | 836篇 |
2008年 | 836篇 |
2007年 | 762篇 |
2006年 | 618篇 |
2005年 | 645篇 |
2004年 | 512篇 |
2003年 | 502篇 |
2002年 | 463篇 |
2001年 | 397篇 |
2000年 | 308篇 |
1999年 | 284篇 |
1998年 | 259篇 |
1997年 | 234篇 |
1996年 | 176篇 |
1995年 | 152篇 |
1994年 | 167篇 |
1993年 | 105篇 |
1992年 | 101篇 |
1991年 | 91篇 |
1990年 | 78篇 |
1989年 | 46篇 |
1988年 | 44篇 |
1987年 | 41篇 |
1986年 | 39篇 |
1985年 | 69篇 |
1984年 | 41篇 |
1983年 | 49篇 |
1982年 | 38篇 |
1981年 | 40篇 |
1980年 | 21篇 |
1979年 | 18篇 |
1978年 | 7篇 |
1977年 | 10篇 |
1976年 | 7篇 |
1975年 | 3篇 |
Objective
To assay peripheral inter-ictal cytokine serum levels and possible relations with non-invasive vagus nerve stimulation (nVNS) responsiveness in migraineurs.Methods
This double-blinded, sham-controlled study enrolled 48 subjects and measured headache severity, frequency [headache days/month, number of total and mild/moderate/severe classified attacks/month], functional state [sleep, mood, body weight, migraine-associated disability] and serum levels of inflammatory markers [inter-ictal] using enzyme-linked immunoassays at baseline and after 2 months of adjunctive nVNS compared to sham stimulation and suitably matched controls.Results
No significant differences were observed at baseline and after 2 months for headache severity, total attacks/month, headache days/month and functional outcome [sleep, mood, disability] between verum and sham nVNS. However, the number of severe attacks/month significantly decreased in the verum nVNS group and circulating pro-inflammatory IL-1β was elevated significantly in the sham group compared to nVNS. Levels of anti-inflammatory IL-10 were significantly higher at baseline in both groups compared to healthy controls, but not at 2 months follow-up [p?<?0.05]. Concentrations of high-mobility group box-1 (HMGB-1), IL-6, tumor-necrosis factor-α (TNF-α), leptin, adiponectin, ghrelin remained unchanged [p?>?0.05]. No severe device-/stimulation-related adverse events occurred.Conclusion
2 months of adjunctive cervical nVNS significantly declined the number of severe attacks/month. Pro-inflammatory IL-1β plasma levels [inter-ictal] were higher in sham-treated migraine patients compared to verum nVNS. However, pro- [IL-6, HMGB-1, TNF-α, leptin] and anti-inflammatory [IL-10, adiponectin, ghrelin] mediators did not differ statistically. Profiling of neuroinflammatory circuits in migraine to predict nVNS responsiveness remains an experimental approach, which may be biased by pre-analytic variables warranting large-scale biobank-based systematic investigations [omics]. 相似文献Butyrylcholinesterase (BChE) is a serine esterase that plays a role in the detoxification of natural as well as synthetic ester-bond-containing compounds. Alterations in BChE activity are associated with a number of diseases. Cholinergic system abnormalities in particular are correlated with the formation of senile plaques in Alzheimer’s disease (AD), and administration of cholinesterase inhibitors is a common therapeutic approach used to treat AD.
Here, our aim was to study the interaction between BChE and fluoxetine.
Molecular docking simulations revealed that fluoxetine penetrated deep into the active-site gorge of BChE and that it was engaged in stabilizing noncovalent interactions with multiple subsites. In substrate kinetic studies, the Vm, Km, kcat and kcat/Km values were found to be 20.59?±?0.36?U mg?1 protein, 194?±?14?µM, 1.3?×?108?s?1 and 6.7?×?105?µM?1s?1, respectively. Based on inhibitory studies, fluoxetine appeared to inhibit BChE competitively, with an IC50 value of 104?µM and a Ki value of 36.3?±?4.7?µM.
Overall, both the low Ki value and the high number of BChE–fluoxetine interactions suggest that fluoxetine is a potent inhibitor of BChE, although in vivo mechanisms for the direct effects of BChE inhibition on various pathologies remain to be further investigated.